Should aprotinin be reconsidered for use in pediatric surgery?

Paediatr Anaesth. 2014 Feb;24(2):137-40. doi: 10.1111/pan.12312.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antifibrinolytic Agents / adverse effects
  • Antifibrinolytic Agents / therapeutic use*
  • Aprotinin / adverse effects
  • Aprotinin / therapeutic use*
  • Blood Loss, Surgical / prevention & control
  • Child
  • General Surgery*
  • Hemostatics / adverse effects
  • Hemostatics / therapeutic use*
  • Humans
  • Pediatrics*
  • United States

Substances

  • Antifibrinolytic Agents
  • Hemostatics
  • Aprotinin